Skip to main content

Table 1 Clinical characteristics of the patients involved in this study

From: Indicators of male fertility potential in adult patients with beta-thalassemia major: a comparative study between patients undergone allogeneic stem cell transplantation and transfusion-dependent patients

 

Transfusion-dependent patients

Patients undergoing HSCT

p-value

Number

52

43

 

Age, years (mean ± SD)

27.31 ± 4.34

23.64 ± 6.11

0.84

Tanner Staging n (%)

P1

1 (1.9%)

1 (2.3%)

0.40

P2

8 (15.4%)

9 (20.9%)

P3

18 (34.6%)

10 (23.3%)

P4

20 (38.5%)

8 (18.6%)

P5

5 (9.6%)

6 (14%)

missing

–

9 (20.9%)

 

Right testis (mean ± SD)

11.10 ± 5.24

11.84 ± 9.22

0.005

Left testis (mean ± SD)

11.80 ± 5.77

11.06 ± 8.27

0.6

FSH (mean ± SD)

3.44 ± 2.12

8.17 ± 10.41

0.003

LH (mean ± SD)

4.49 ± 2.76

6.33 ± 3.82

0.22

Testosterone (mean ± SD)

4.61 ± 3.15

4.04 ± 2.57

0.1

TSH (mean ± SD)

3.67 ± 2.38

3.64 ± 2.64

0.7

T4 (mean ± SD)

7.59 ± 1.91

16.82 ± 3.67

0.003

Hypogonadism, n (%)

16 (30.8%)

15 (36.6%)

0.35

 

10 (19.2%)

6 (14.6%)

0.38

Semen

Volume

Normal

38

9

0.00

Low

9

23

Dry ejaculate

5

11

Viscosity

High

2

2

0.21

Normal

44

29

Low

1

1

Dry ejaculate

5

11

Agglutination

Few

1

1

0.21

Rare

1

1

None

45

30

Dry ejaculate

5

11

Sperm

Concentration

Normal

31

16

0.017

Oligospermia

9

5

Azoospermia

12

22

Total motility

Normal

31

16

0.017

< 40%

9

5

Azoospermia

12

22

Progressive motility

Normal

26

14

0.017

< 32%

14

7

Azoospermia

12

22

Shape

Normal

32

19

0.005

< 4%

8

1

Azoospermia

12

22